美国 · 交易所与实时行情 · Nasdaq
Johnson & Johnson To Acquire Ollin Biosciences In $2.2 Bln Deal
详细摘要
(RTTNews) - Healthcare company Johnson & Johnson (JNJ) announced on Monday that it has agreed to acquire clinical-stage biopharmaceutical company Ollin Biosciences for $2.2…
MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.nasdaq.com)


